Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial.
Saved in:
| Title: | Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. |
|---|---|
| Authors: | Kumar, Deepali1 (AUTHOR), Ison, Michael G2 (AUTHOR), Mira, Jean-Paul3 (AUTHOR), Welte, Tobias4 (AUTHOR), Hwan Ha, Jick5 (AUTHOR), Hui, David S6 (AUTHOR), Zhong, Nanshan7 (AUTHOR), Saito, Takefumi8 (AUTHOR), Katugampola, Laurie9 (AUTHOR), Collinson, Neil9 (AUTHOR), Williams, Sarah9 (AUTHOR), Wildum, Steffen10 (AUTHOR), Ackrill, Andrew9 (AUTHOR), Clinch, Barry9 (AUTHOR), Lee, Nelson1,11,12 (AUTHOR) nelsonls.lee@utoronto.ca |
| Source: | Lancet Infectious Diseases. May2022, Vol. 22 Issue 5, p718-730. 13p. |
| Database: | Academic Search Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 156420383 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Kumar%2C+Deepali%22">Kumar, Deepali</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ison%2C+Michael+G%22">Ison, Michael G</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Mira%2C+Jean-Paul%22">Mira, Jean-Paul</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Welte%2C+Tobias%22">Welte, Tobias</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hwan+Ha%2C+Jick%22">Hwan Ha, Jick</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hui%2C+David+S%22">Hui, David S</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhong%2C+Nanshan%22">Zhong, Nanshan</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Saito%2C+Takefumi%22">Saito, Takefumi</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Katugampola%2C+Laurie%22">Katugampola, Laurie</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Collinson%2C+Neil%22">Collinson, Neil</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Williams%2C+Sarah%22">Williams, Sarah</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Wildum%2C+Steffen%22">Wildum, Steffen</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Ackrill%2C+Andrew%22">Ackrill, Andrew</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Clinch%2C+Barry%22">Clinch, Barry</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lee%2C+Nelson%22">Lee, Nelson</searchLink><relatesTo>1,11,12</relatesTo> (AUTHOR)<i> nelsonls.lee@utoronto.ca</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Lancet+Infectious+Diseases%22">Lancet Infectious Diseases</searchLink>. May2022, Vol. 22 Issue 5, p718-730. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=156420383 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/S1473-3099(21)00469-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 718 Titles: – TitleFull: Combining baloxavir marboxil with standard-of-care neuraminidase inhibitor in patients hospitalised with severe influenza (FLAGSTONE): a randomised, parallel-group, double-blind, placebo-controlled, superiority trial. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kumar, Deepali – PersonEntity: Name: NameFull: Ison, Michael G – PersonEntity: Name: NameFull: Mira, Jean-Paul – PersonEntity: Name: NameFull: Welte, Tobias – PersonEntity: Name: NameFull: Hwan Ha, Jick – PersonEntity: Name: NameFull: Hui, David S – PersonEntity: Name: NameFull: Zhong, Nanshan – PersonEntity: Name: NameFull: Saito, Takefumi – PersonEntity: Name: NameFull: Katugampola, Laurie – PersonEntity: Name: NameFull: Collinson, Neil – PersonEntity: Name: NameFull: Williams, Sarah – PersonEntity: Name: NameFull: Wildum, Steffen – PersonEntity: Name: NameFull: Ackrill, Andrew – PersonEntity: Name: NameFull: Clinch, Barry – PersonEntity: Name: NameFull: Lee, Nelson IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: May2022 Type: published Y: 2022 Identifiers: – Type: issn-print Value: 14733099 Numbering: – Type: volume Value: 22 – Type: issue Value: 5 Titles: – TitleFull: Lancet Infectious Diseases Type: main |
| ResultId | 1 |